The Rajiv Arogya Bhagya scheme provides subsidized tertiary healthcare to APL card holders in Karnataka for 7 super specialties including cardiology, neurosurgery, and oncology. It is implemented through an assurance model with financial coverage up to Rs. 1.5 lakhs per beneficiary from the Suvarna Arogya Suraksha Trust. Treatment is provided through an empaneled network of over 145 public and private hospitals. The scheme utilizes a co-payment mechanism where beneficiaries pay 30% of costs for general wards or 50% of costs for semi-private or private wards. Information on the scheme can be accessed through the mobile application or websites.
This information sheet provides an overview of how we are delivering national technology services, including Spine Services, NHSmail and the Summary Care Record (SCR).
We are commissioned by NHS England and the Department of Health to manage informatics projects and programmes that support clinical decision making, NHS working practice and improved patient outcomes.
Are you navigating through the new CCJR Payment Model? Let Intralign help your facility with our CCJR infographic detailing what CCJR is and how to prepare.
PPP in Healthcare- An Indian Perspective, World Bank MOOC, By Saurav Kumar Dassauravkumar das
Having undertaken this course in the “Policy and Practice Track” I intend the presentation to be of value to policy makers and ground level stakeholders in the healthcare sector. The main purpose of the presentation was to provide the major challenges and opportunities for Healthcare PPPs in the Indian context. I envisage it to be of help for government agencies as well as private healthcare players. It would also be helpful to researchers and NGOs who are working in the healthcare sector. The presentation dives deep into the different PPP models and highlights some of the success stories under each model. It also touches upon certain key risks and drivers of success under challenging circumstances.
This information sheet provides an overview of how we are delivering national technology services, including Spine Services, NHSmail and the Summary Care Record (SCR).
We are commissioned by NHS England and the Department of Health to manage informatics projects and programmes that support clinical decision making, NHS working practice and improved patient outcomes.
Are you navigating through the new CCJR Payment Model? Let Intralign help your facility with our CCJR infographic detailing what CCJR is and how to prepare.
PPP in Healthcare- An Indian Perspective, World Bank MOOC, By Saurav Kumar Dassauravkumar das
Having undertaken this course in the “Policy and Practice Track” I intend the presentation to be of value to policy makers and ground level stakeholders in the healthcare sector. The main purpose of the presentation was to provide the major challenges and opportunities for Healthcare PPPs in the Indian context. I envisage it to be of help for government agencies as well as private healthcare players. It would also be helpful to researchers and NGOs who are working in the healthcare sector. The presentation dives deep into the different PPP models and highlights some of the success stories under each model. It also touches upon certain key risks and drivers of success under challenging circumstances.
Why You Need to Understand Value-Based Reimbursement and How to Survive ItHealth Catalyst
There are clear signs the healthcare industry is in the midst of a shift to value-based reimbursement. The most noticeable signs are the recent and proposed 2015 rulings from CMS. There are four areas in value-based reimbursement that will be impacted by the end of 2015: the physician payment structure, bundled payments, Inpatient Prospective Payment Systems regulations, and commercial payers. To survive the shift to value-based reimbursement, it’s important for providers and payers to take three steps: provide access to rich data, share knowledge and learn from each other, develop strategies by doing assessments.
Essential Package of Health Services and Health Benefit Plans Mapping BriefHFG Project
Many governments are scaling up health benefit plans, such as social health insurance, to increase population health coverage. This brief presents findings from a mapping between the services covered under the country’s prominent health benefit plan(s) to the country’s Essential Package of Health Services. The mapping analyzes the extent to which the plan(s) cover essential services.
The CMS Innovation Center held a Comprehensive Care for Joint Replacement Model webinar on proposed rule changes to the model on September 7, 2016.
- - -
CMS Innovation Center
http://innovation.cms.gov
We accept comments in the spirit of our comment policy:
http://newmedia.hhs.gov/standards/comment_policy.html
CMS Privacy Policy
http://cms.gov/About-CMS/Agency-Information/Aboutwebsite/Privacy-Policy.html
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
Why You Need to Understand Value-Based Reimbursement and How to Survive ItHealth Catalyst
There are clear signs the healthcare industry is in the midst of a shift to value-based reimbursement. The most noticeable signs are the recent and proposed 2015 rulings from CMS. There are four areas in value-based reimbursement that will be impacted by the end of 2015: the physician payment structure, bundled payments, Inpatient Prospective Payment Systems regulations, and commercial payers. To survive the shift to value-based reimbursement, it’s important for providers and payers to take three steps: provide access to rich data, share knowledge and learn from each other, develop strategies by doing assessments.
Essential Package of Health Services and Health Benefit Plans Mapping BriefHFG Project
Many governments are scaling up health benefit plans, such as social health insurance, to increase population health coverage. This brief presents findings from a mapping between the services covered under the country’s prominent health benefit plan(s) to the country’s Essential Package of Health Services. The mapping analyzes the extent to which the plan(s) cover essential services.
The CMS Innovation Center held a Comprehensive Care for Joint Replacement Model webinar on proposed rule changes to the model on September 7, 2016.
- - -
CMS Innovation Center
http://innovation.cms.gov
We accept comments in the spirit of our comment policy:
http://newmedia.hhs.gov/standards/comment_policy.html
CMS Privacy Policy
http://cms.gov/About-CMS/Agency-Information/Aboutwebsite/Privacy-Policy.html
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Struggling with intense fears that disrupt your life? At Renew Life Hypnosis, we offer specialized hypnosis to overcome fear. Phobias are exaggerated fears, often stemming from past traumas or learned behaviors. Hypnotherapy addresses these deep-seated fears by accessing the subconscious mind, helping you change your reactions to phobic triggers. Our expert therapists guide you into a state of deep relaxation, allowing you to transform your responses and reduce anxiety. Experience increased confidence and freedom from phobias with our personalized approach. Ready to live a fear-free life? Visit us at Renew Life Hypnosis..
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
2. INTRODUCTION
The Government of Karnataka has approved a Health Assurance Scheme vide
Government order G.O. No. Akuka 343 CGE 2013.
Specially designed for…
Get subsidised treatment
Get cashless treatment
3. Objectives of RAB
To provide better quality of “Tertiary Health Care”
Better & affordable treatment of catastrophic
illnesses involving hospitalization, surgery, and
other therapies.
4. Coverage of RAB
APL card holders
The APL cards should be issued by the Food and Civil
Supplies Department.
5. Scheme design
The scheme shall get implemented in an “Assurance Mode”
with a component of “Co-payment” payable by the APL
beneficiary to the “Empanelled Network Treating Hospital”.
Finance is assured by the Government through Suvarna
Arogya Suraksha Trust.
Financial assurance shall be limited to Rs. 1.5 lakhs.
The scheme shall also allow a buffer of Rs. 50,000/-, which
shall get sanctioned at the discretion of the Executive
Director, Suvarna Arogya Suraksha Trust.
6. Benefits in the RAB Scheme
Subsidized care for 449 procedures under 7 broad super
specialties of
Cardiology (includes cardiothoracic surgery, cardiovascular
surgery and other cardiac procedures)
Neurosurgery (includes Cranial, Spinal and peripheral
neurosurgical procedures)
Genitourinary Surgeries (includes renal and congenital
genital malformations)
Oncology (medical, surgical and radiation),
Paediatric Surgeries (includes neonatal procedures)
Polytrauma (includes injury with associated multi-organ
involvement) and Burns (includes electrical shocks )
7. Empanelled network
The treatment providers under this scheme is the network of
more than 145 Hospitals both in the Public and Private sector
ex: BGS global hospitals, Indira Gandhi institute of child health,
Kidwai institute of oncology , Narayana hrudayalaya hospitals
etc.
8. Co-Payment Mechanism
For General Ward :– The “Basic Package Rate” alone is
admissible and it is shared between the Suvarna Arogya
Suraksha Trust and the Beneficiary in the ratio of 70%:30%
and these wards are not entitled for any upgraded services.
For Semi private / Private ward : 50% of general ward rate
9. Example of Co-Payment Mechanism
* For Procedure CABG
General ward Rate : Rs.95000
Hospital Declared Rate for Semi Private ward is
Rs. 125000
Hospital declared Rate for Private Ward : Rs. 150000.
10. * Option 1:
If Patient opts for General Ward for CABG .
Govt Share: Rs 66500 ( 70% of the General Ward charges will be given)
Patient Share: Rs 28500 ( Rs95000 – Rs.66500).
* Option 2:
If Patient opts for Semi private Ward for CABG.
Govt Share: Rs 47500 (50% of the General Ward charges will be given)
Patient Share: Rs 77,500 ( Rs125000 – Rs.47500).
* Option 3:
If Patient opts for private Ward for CABG.
Govt Share: Rs 47500 (50% of the General Ward will be given)
Patient Share: Rs 1,02,500 ( Rs150000 – Rs.47500).
11. How to Access the Scheme
* Method 1:
The information can be accessed through web based (internet) by
typing the below website address:
www.rajivarogya.org
www.rajivarogya.com
www.rajivarogya.in
* Method 2:
Mobiles based Android App: App can be downloaded from Google
Play store by typing “rajivarogya”.
Mobiles based Apple App: App can be downloaded from Apple App
store by typing “rajivarogya”.
12. Summary
Objective to provide “Tertiary Health Care”
Beneficiaries are APL card holders
7 broad super specialties
Scheme design and financial limit
Co payment mechanism
Mobile application